Article: Nabilone relieves many advanced Ca symptoms.(Clinical Rounds)(cancer)

SAN ANTONIO -- The synthetic cannabinoid nabilone appears to be of substantial benefit in managing multiple symptoms common among patients with advanced cancer, thereby minimizing problems caused by polypharmacy, Dr. Vincent Maida reported at a breast cancer symposium sponsored by the Cancer Therapy and Research Center.

His retrospective observational study showed that nabilone (Cesamet) resulted in a significant reduction in the overall cancer-related distress score on the validated Edmonton Symptom Assessment System (ESAS).

The specific symptoms included in the scale that showed significant improvement in response to this off-label use of nabilone were ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!